MYGN:NASDAQ
Myriad Genetics Inc
$4.28
arrow_upward
+0.12%(+0.0050) 1D
Jun 2, 12:22:42 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$4.22
High
$4.31
Low
$4.12
Mkt. cap
404.71M
Avg. vol.
1.76M
Volume
540.59K
52-wk high
$8.59
52-wk low
$3.53
EPS
-$4.32
Beta
1.73
Shares outstanding
94.45M
No. of employees
3K
Open
$4.22
High
$4.31
Low
$4.12
Mkt. cap
404.71M
Avg. vol.
1.76M
Volume
540.59K
52-wk high
$8.59
52-wk low
$3.53
EPS
-$4.32
Beta
1.73
Shares outstanding
94.45M
No. of employees
3K
News stories
From sources across the web
Investing.com
·
2 hours ago
Myriad Genetics names Raj Jampa as chief technology officer
Stock Titan
·
3 hours ago
New CTO Raj Jampa to modernize tech and AI at Myriad Genetics
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com
AI content may include mistakes. Learn more